Cargando…

BMP4-SMAD1/5/9-RUNX2 pathway activation inhibits neurogenesis and oligodendrogenesis in Alzheimer’s patients’ iPSCs in senescence-related conditions

Mostrar otras versiones (1)

Detalles Bibliográficos
Autores principales:	Nakatsu, Daiki, Kunishige, Rina, Taguchi, Yuki, Shinozaki-Narikawa, Naeko, Osaka, Kishiko, Yokomizo, Kayo, Ishida, Mami, Takei, Shunsuke, Yamasaki, Shoko, Hagiya, Keita, Hattori, Kotaro, Tsukamoto, Tadashi, Murata, Masayuki, Kano, Fumi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10202651/ https://www.ncbi.nlm.nih.gov/pubmed/37163982 http://dx.doi.org/10.1016/j.stemcr.2023.03.017

Ejemplares similares

BMP4-SMAD1/5/9-RUNX2 pathway activation inhibits neurogenesis and oligodendrogenesis in Alzheimer’s patients’ iPSCs in senescence-related conditions
por: Nakatsu, Daiki, et al.
Publicado: (2023)

Pyk2-dependent phosphorylation of LSR enhances localization of LSR and tricellulin at tricellular tight junctions
por: Nakatsu, Daiki, et al.
Publicado: (2019)

The Cruciality of Single Amino Acid Replacement for the Spectral Tuning of Biliverdin-Binding Cyanobacteriochromes
por: Fushimi, Keiji, et al.
Publicado: (2020)

Lucky iPSCs
por: Zviran, Asaf, et al.
Publicado: (2014)

iPSCs are safe!
por: Yan, Hualong, et al.
Publicado: (2017)

Targeted Integration of Inducible Caspase-9 in Human iPSCs Allows Efficient in vitro Clearance of iPSCs and iPSC-Macrophages
por: Lipus, Alexandra, et al.
Publicado: (2020)

Mitochondria fingerprint longevity in iPSCs
por: Masotti, Andrea, et al.
Publicado: (2015)

Applications of iPSCs in Cancer Research
por: Kim, Jean J
Publicado: (2015)

Reducing genomic instability in iPSCs
por: Ruiz, Sergio, et al.
Publicado: (2015)

The Challenge of Bringing iPSCs to the Patient
por: Ortuño-Costela, María del Carmen, et al.
Publicado: (2019)

iPSCs in Modeling and Therapy of Osteoarthritis
por: Csobonyeiova, Maria, et al.
Publicado: (2021)

Modeling Alexander disease with patient iPSCs reveals cellular and molecular pathology of astrocytes
por: Kondo, Takayuki, et al.
Publicado: (2016)

Microscopic image-based covariation network analysis for actin scaffold-modified insulin signaling
por: Noguchi, Yoshiyuki, et al.
Publicado: (2021)

iPSCs: From Bench to Clinical Bed
por: Li, Yujing, et al.
Publicado: (2016)

Differentiation of human iPSCs into functional podocytes
por: Rauch, Caroline, et al.
Publicado: (2018)

Yip1A, a Novel Host Factor for the Activation of the IRE1 Pathway of the Unfolded Protein Response during Brucella Infection
por: Taguchi, Yuki, et al.
Publicado: (2015)

Erratum to: Modeling Alexander disease with patient iPSCs reveals cellular and molecular pathology of astrocytes
por: Kondo, Takayuki, et al.
Publicado: (2016)

Chromatin remodeling in oligodendrogenesis
por: Antontseva, E.V., et al.
Publicado: (2021)

Nanog-Independent Reprogramming to iPSCs with Canonical Factors
por: Carter, Ava C., et al.
Publicado: (2014)

Disease, iPSCs and a Quest for the Perfect Model
Publicado: (2016)

Clinical Therapy Using iPSCs: Hopes and Challenges
por: Lu, Xiao, et al.
Publicado: (2013)

The Potential of iPSCs for the Treatment of Premature Aging Disorders
por: Compagnucci, Claudia, et al.
Publicado: (2017)

The tale of autologous iPSCs: A monkey perspective
por: Li, Fei
Publicado: (2014)

Tumorigenicity risk of iPSCs in vivo: nip it in the bud
por: Zhong, Chaoliang, et al.
Publicado: (2022)

Functional genomics and the future of iPSCs in disease modeling
por: Brooks, Imogen R., et al.
Publicado: (2022)

Modelling urea cycle disorders using iPSCs
por: Duff, Claire, et al.
Publicado: (2022)

iPSCs in NK Cell Manufacturing and NKEV Development
por: Boyd-Gibbins, Nicholas, et al.
Publicado: (2022)

MSCs vs. iPSCs: Potential in therapeutic applications
por: Thanaskody, Kalaiselvaan, et al.
Publicado: (2022)

Identifying the dynamics of actin and tubulin polymerization in iPSCs and in iPSC-derived neurons
por: Magliocca, Valentina, et al.
Publicado: (2017)

Deficiency in MT5-MMP Supports Branching of Human iPSCs-Derived Neurons and Reduces Expression of GLAST/S100 in iPSCs-Derived Astrocytes
por: Arnst, Nikita, et al.
Publicado: (2021)

Modelling DMD-associated cardiomyopathy in patient-derived iPSCs
Publicado: (2015)

The State of Play with iPSCs and Spinal Cord Injury Models
por: Hodgetts, Stuart I., et al.
Publicado: (2015)

An Overview of Direct Somatic Reprogramming: The Ins and Outs of iPSCs
por: Menon, Siddharth, et al.
Publicado: (2016)

Epigenetic Modifiers Facilitate Induction and Pluripotency of Porcine iPSCs
por: Mao, Jian, et al.
Publicado: (2016)

Apoptosis in Porcine Pluripotent Cells: From ICM to iPSCs
por: Kim, Eunhye, et al.
Publicado: (2016)

Microhomology-assisted scarless genome editing in human iPSCs
por: Kim, Shin-Il, et al.
Publicado: (2018)

The rebirth of iPSCs: Towards a healthier epigenetic landscape
por: Li, Fei
Publicado: (2014)

Genomic Instability of iPSCs: Challenges Towards Their Clinical Applications
por: Yoshihara, Masahito, et al.
Publicado: (2016)

Protocol for Differentiation of Human iPSCs into Pulmonary Neuroendocrine Cells
por: Hor, Pooja, et al.
Publicado: (2020)

Pannexin 1 Influences Lineage Specification of Human iPSCs
por: Noort, Rebecca J., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_7lo4dif5786epeif5h1bo9mbib